1D228, a c-Met/TRK inhibitor with antitumor properties, suppresses cyclin D1 to precipitate G0/G1 arrest, thereby inhibiting proliferation and migration of cancer cells. This compound is applicable in researching gastric, liver, and vascular tumors [1].
Target:
c-Met/HGFR|||Trk receptor
* VAT and and shipping costs not included. Errors and price changes excepted
